Procalcitonin in young febrile infants for the detection of serious bacterial infections

被引:109
作者
Maniaci, Vincenzo [1 ,2 ]
Dauber, Andrew [2 ]
Weiss, Scott [2 ]
Nylen, Eric [3 ,4 ]
Becker, Kenneth L. [3 ,4 ]
Bachur, Richard [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Div Emergency Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA USA
[3] Vet Affairs Med Ctr, Dept Med, Washington, DC 20422 USA
[4] George Washington Univ, Med Ctr, Dept Med, Washington, DC 20037 USA
基金
美国国家卫生研究院;
关键词
fever; infant; serious bacterial infection; urinary tract infection; bacteremia; procalcitonin; diagnostic tests;
D O I
10.1542/peds.2007-3503
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVES. The objectives of the study were (1) to study the test performance of procalcitonin for identifying serious bacterial infections in febrile infants <= 90 days of age without an identifiable bacterial source and (2) to determine an optimal cutoff value to identify infants at low risk for serious bacterial infections. METHODS. A prospective observational study was performed with febrile infants <= 90 days of age presenting to an urban, pediatric, emergency department. Serum procalcitonin levels were measured by using an automated high-sensitivity assay. An optimal procalcitonin cutoff value was selected to maximize sensitivity and negative predictive value for the detection of serious bacterial infections. Infants were classified as having definite, possible, or no serious bacterial infections. RESULTS. A total of 234 infants (median age: 51 days) were studied. Thirty infants (12.8%) had definite serious bacterial infections (bacteremia: n = 4; bacteremia with urinary tract infections: n = 2; urinary tract infections: n = 24), and 12 infants (5.1%) had possible serious bacterial infections (pneumonia: n = 5; urinary tract infections: n = 7). Mean procalcitonin levels for definite serious bacterial infections (2.21 +/- 3.9 ng/mL) and definite plus possible serious bacterial infections (2.48 +/- 4.6 ng/mL) were significantly higher than that for no serious bacterial infection (0.38 +/- 1.0 ng/mL). The area under the receiver operating characteristic curve was 0.82 for definite serious bacterial infections and 0.76 for definite and possible serious bacterial infections. For identifying definite and possible serious bacterial infections, a cutoff value of 0.12 ng/mL had sensitivity of 95.2%, specificity of 25.5%, negative predictive value of 96.1%, and negative likelihood ratio of 0.19; all cases of bacteremia were identified accurately with this cutoff value. CONCLUSIONS. Procalcitonin has favorable test characteristics for detecting serious bacterial infections in young febrile infants. Procalcitonin measurements performed especially well in detecting the most serious occult infections.
引用
收藏
页码:701 / 710
页数:10
相关论文
共 69 条
[1]   Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department [J].
Andreola, Barbara ;
Bressan, Silvia ;
Callegaro, Silvia ;
Liverani, Anna ;
Plebani, Mario ;
Da Dalt, Liviana .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (08) :672-677
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]   Procalcitonin:: A marker of neonatal sepsis [J].
Atlihan, F ;
Akagündüz, B ;
Genel, F ;
Bak, M ;
Can, D .
JOURNAL OF TROPICAL PEDIATRICS, 2002, 48 (01) :10-14
[4]   Predictive model for serious bacterial infections among infants younger than 3 months of age [J].
Bachur, RG ;
Harper, MB .
PEDIATRICS, 2001, 108 (02) :311-316
[5]  
BAKER MD, 1990, PEDIATRICS, V85, P1040
[6]   OUTPATIENT MANAGEMENT WITHOUT ANTIBIOTICS OF FEVER IN SELECTED INFANTS [J].
BAKER, MD ;
BELL, LM ;
AVNER, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1437-1441
[7]  
BARAFF LJ, 1994, NEW ENGL J MED, V330, P938
[8]  
BARAFF LJ, 1993, PEDIATRICS, V92, P1
[9]   PRACTICE GUIDELINE FOR THE MANAGEMENT OF INFANTS AND CHILDREN 0 TO 36 MONTHS OF AGE WITH FEVER WITHOUT SOURCE [J].
BARAFF, LJ ;
BASS, JW ;
FLEISHER, GR ;
KLEIN, JO ;
MCCRACKEN, GH ;
POWELL, KR ;
SCHRIGER, DL .
ANNALS OF EMERGENCY MEDICINE, 1993, 22 (07) :1198-1210
[10]   OUTPATIENT TREATMENT OF FEBRILE INFANTS 28 TO 89 DAYS OF AGE WITH INTRAMUSCULAR ADMINISTRATION OF CEFTRIAXONE [J].
BASKIN, MN ;
OROURKE, EJ ;
FLEISHER, GR .
JOURNAL OF PEDIATRICS, 1992, 120 (01) :22-27